Skip to Content
Merck
  • Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma.

Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma.

Molecular cancer research : MCR (2020-12-09)
Myriam Cerezo-Magaña, Helena C Christianson, Toin H van Kuppevelt, Karin Forsberg-Nilsson, Mattias Belting
ABSTRACT

As an adaptive response to hypoxic stress, aggressive tumors rewire their metabolic phenotype into increased malignant behavior through extracellular lipid scavenging and storage in lipid droplets (LD). However, the underlying mechanisms and potential lipid source retrieved in the hypoxic tumor microenvironment remain poorly understood. Here, we show that exosome-like extracellular vesicles (EV), known as influential messengers in the tumor microenvironment, may also serve anabolic functions by transforming hypoxic, patient-derived human glioblastoma cell lines into the LD+ phenotype. EVs were internalized via a hypoxia-sensitive, endocytic mechanism that fueled LD formation through direct lipid transfer, and independently of fatty acid synthase activity. EVs can enter cells through multiple and yet ill-defined pathways. On a mechanistic level, we found that hypoxia-mediated EV uptake depends on increased heparan sulfate proteoglycan (HSPG) endocytosis that preferentially followed the lipid raft pathway. The functional relevance of HSPG was evidenced by the reversal of EV-mediated LD loading by targeting of HSPG receptor function. IMPLICATIONS: Together, our data extend the multifaceted role of EVs in cancer biology by showing their LD-inducing capacity in hypoxic glioma cells. Moreover, these findings highlight a potential function for HSPG-mediated endocytosis as a salvage pathway for EV retrieval during tumor stress conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PKH67 Green Fluorescent Cell Linker Midi Kit for General Cell Membrane Labeling, Distributed for Phanos Technologies
Sigma-Aldrich
Heparinase I from Flavobacterium heparinum, Lyophilized powder stabilized with approx. 25% bovine serum albumin, ≥200 units/mg protein (enzyme + BSA)
Sigma-Aldrich
Heparinase III from Flavobacterium heparinum, Lyophilized powder stabilized with approx. 25% (w/w) bovine serum albumin, ≥30 units/mg protein (enzyme + BSA)
Sigma-Aldrich
Filipin III from Streptomyces filipinensis, ≥85% (HPLC)
Sigma-Aldrich
Fluorescein isothiocyanate–dextran, average mol wt 10,000
Sigma-Aldrich
Cholesterol, Sigma Grade, ≥99%
Sigma-Aldrich
Fasnall benzenesulfonate salt, ≥98% (HPLC)
Sigma-Aldrich
Anti-Chondroitin Sulfate antibody, Mouse monoclonal, clone CS-56, purified from hybridoma cell culture
Sigma-Aldrich
DMOG, ≥98% (HPLC)
Sigma-Aldrich
4-Nitrophenyl β-D-xylopyranoside, ≥98%
Sigma-Aldrich
Heparin sodium salt from porcine intestinal mucosa, Grade I-A, ≥180 USP units/mg
Sigma-Aldrich
Monoclonal Anti-VSV Glycoprotein antibody produced in mouse, clone P5D4, ascites fluid
Sigma-Aldrich
GSK2194069, ≥97% (HPLC)
Sigma-Aldrich
PKH26 Red Fluorescent Cell Linker Midi Kit for General Cell Membrane Labeling, Distributed for Phanos Technologies